ConductScience.org, home

Gene · 6921

ELOC: elongin C

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ELOC: elongin C. Genes, record 6921. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6921

On this page

Gene

Symbol
ELOC
HGNC
Name
elongin C
HGNC
NCBI Gene ID
6921
NCBI Gene
HGNC ID
HGNC:11617
HGNC
Ensembl
ENSG00000154582
NCBI Gene
Aliases
SIII, TCEB1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q15369Elongin-C112226Ensembl, GeneID, HGNC

Source UniProt

Patents146

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1467350Q15369Espacenet
JP 2026004568 A2026-01-1467351Q15369Espacenet
JP 2026004568 A2026-01-1467352Q15369Espacenet
JP 2026004568 A2026-01-1467353Q15369Espacenet
JP 2026004568 A2026-01-1467354Q15369Espacenet
JP 2026004568 A2026-01-1467355Q15369Espacenet
EP 4253412 A22023-10-0415Q15369Espacenet
US 11492404 B22022-11-0815Q15369Espacenet
US 11446398 B22022-09-2089608Q15369Espacenet
US 11446398 B22022-09-2089609Q15369Espacenet

1 to 10 of 146

See all 146 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,232

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleELOC papersNewest fiscal year
P30CA016672Cancer Center Support Grant132025
ZIABC011028Clinical Studies of the Molecular Genetic Basis of Kidney Cancer132025
ZIABC011038Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene132025
P30CA008748Cancer Center Support Grant112025
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control112025
ZIABC011043Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene112025
P30CA021765Cancer Center Support Grant (CCSG)102025
ZIDBC011089Clinical Nursing and Data Management Core102025
P30AI027763UCSF-Bay Area Center for AIDS Research72025
P30CA016086Cancer Center Support Grant72025

1 to 10 of 1,232Source NIH's project files

See all 1,232 nih grants

Papers1,693

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Molecular underpinnings of metastatic small renal masses.JCI Insight202642770303PubTator, text miningPubMed
Adult Mixed Epithelial and Stromal Tumor of the Kidney Harbors Recurrent Whole Chromosome 12 Gain.Am J Surg Pathol202642750419PubTator, text miningPubMed
Chemical tools for BAZ2A/B biology: discovery of dual and BAZ2B-selective PROTAC degraders.RSC Med Chem202642626597PubTator, text miningPubMed
Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD).Cancer Metastasis Rev202642593521PubTator, text miningPubMed
Evolutionary convergence and niche-specific regulation of core HIF1A pathway genes synergistically drive divergent hypoxia adaptation in mammals.BMC Ecol Evol202642477533PubTator, text miningPubMed
Proteomic Analysis Identifies Potential Biomarkers of ELOC -Mutated Renal Cell Carcinoma.Am J Surg Pathol202642438270PubTator, text miningPubMed
Alphavirus M1 disrupts super-enhancer-driven oncogenic transcription via non-structural protein NSP2 in osteosarcoma.Nat Commun202642386745PubTator, text miningPubMed
Clinicopathological and molecular features of uterine smooth muscle tumours in patients with Li-Fraumeni syndrome.Histopathology202642312930PubTator, text miningPubMed
Structure of the E3 ligase CRL2ZYG11B with substrates reveals the molecular basis for N-degron recognition and ubiquitination.Cell Rep202642224082PubTator, text miningPubMed
Targeting the Elongin BC-BC-Box Interface: Structural Insights, Peptidic Disruptors and Emerging Small-Molecule Strategies.Chem Biol Drug Des202642070964PubTator, text miningPubMed

1 to 10 of 1,693

See all 1,693 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/6921

GET https://conductscience.org/api/genes/v1/6921/patents?page=2